N-Nitroso Fedratinib Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Fedratinib is used to treat adults with certain types of myelofibrosis (MF; a cancer of the bone marrow in which the bone marrow is replaced by scar tissue and causes decreased blood cell production). Fedratinib is in a class of medications called kinase inhibitors.N-Nitroso Fedratinib Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Fedratinib Impurity 1 CAS NO:NA Chemically represented as N-(Tert-butyl)-3-((5-methyl-2-(nitroso(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)amino)pyrimidin-4-yl) (nitroso) amino) benzenesulfonamide .Synchemia is the leading manufacturing and exporter of N-Nitroso Fedratinib Impurity 1.We supply N-Nitroso Fedratinib Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141715 |
| CAS No | NA |
| Mol.F. | C9H10N6O3 |
| Mol.Wt. | 250.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141716 |
| CAS No | NA |
| Mol.F. | C8H9N3O5 |
| Mol.Wt. | 227.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141717 |
| CAS No | NA |
| Mol.F. | C20H20N2O3 |
| Mol.Wt. | 336.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141718 |
| CAS No | NA |
| Mol.F. | C20H20N2O4 |
| Mol.Wt. | 352.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141719 |
| CAS No | NA |
| Mol.F. | C20H20N2O5 |
| Mol.Wt. | 368.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141720 |
| CAS No | NA |
| Mol.F. | C29H52N2O6 |
| Mol.Wt. | 524.7 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141721 |
| CAS No | NA |
| Mol.F. | C18H22N2O2 |
| Mol.Wt. | 298.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141722 |
| CAS No | NA |
| Mol.F. | C17H20N2O2 |
| Mol.Wt. | 284.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141723 |
| CAS No | NA |
| Mol.F. | C17H20N2O2 |
| Mol.Wt. | 284.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141724 |
| CAS No | NA |
| Mol.F. | C13H8N2O2S |
| Mol.Wt. | 256.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141725 |
| CAS No | NA |
| Mol.F. | C23H25N3O6 |
| Mol.Wt. | 439.5 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141726 |
| CAS No | 35784-01-1 |
| Mol.F. | C6H10N2O2 |
| Mol.Wt. | 142.16 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141727 |
| CAS No | NA |
| Mol.F. | C16H21N3O4 |
| Mol.Wt. | 319.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141728 |
| CAS No | NA |
| Mol.F. | C22H26N6O5 |
| Mol.Wt. | 454.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141729 |
| CAS No | NA |
| Mol.F. | C15H18N4O3 |
| Mol.Wt. | 302.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141730 |
| CAS No | NA |
| Mol.F. | C15H24N4O3 |
| Mol.Wt. | 308.4 |
| INV STATUS | CUSTOM SYNTHESIS |